The store will not work correctly when cookies are disabled.
N-Benzyl-2-(3-fluoro-phenoxy)-nicotinamide
ID: ALA171394
PubChem CID: 14555262
Max Phase: Preclinical
Molecular Formula: C19H15FN2O2
Molecular Weight: 322.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NCc1ccccc1)c1cccnc1Oc1cccc(F)c1
Standard InChI: InChI=1S/C19H15FN2O2/c20-15-8-4-9-16(12-15)24-19-17(10-5-11-21-19)18(23)22-13-14-6-2-1-3-7-14/h1-12H,13H2,(H,22,23)
Standard InChI Key: KQUXIWCKLIRVAU-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
0.3792 -1.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3792 -1.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9000 -0.9417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9042 -2.1542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4167 -1.2417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.1375 -2.1542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9042 -2.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8917 -0.3417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4250 -3.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9375 -0.9417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4292 -3.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9500 -3.9417 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-0.1375 -0.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4625 -1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3875 -3.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6583 -1.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3875 -3.0500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9042 -3.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9750 -0.9292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4625 -1.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6583 -1.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9792 -2.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4917 -1.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5000 -1.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 1 1 0
5 3 1 0
6 1 2 0
7 4 1 0
8 3 2 0
9 7 1 0
10 5 1 0
11 9 2 0
12 11 1 0
13 2 2 0
14 10 1 0
15 17 1 0
16 6 1 0
17 7 2 0
18 15 2 0
19 14 1 0
20 14 2 0
21 16 2 0
22 20 1 0
23 19 2 0
24 22 2 0
13 21 1 0
11 18 1 0
23 24 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 322.34 | Molecular Weight (Monoisotopic): 322.1118 | AlogP: 3.94 | #Rotatable Bonds: 5 |
Polar Surface Area: 51.22 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.92 | CX Basic pKa: 1.70 | CX LogP: 3.79 | CX LogD: 3.79 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.77 | Np Likeness Score: -1.89 |
References
1. Vinick FJ, Saccomano NA, Koe BK, Nielsen JA, Williams IH, Thadeio PF, Jung S, Meltz M, Johnson J, Lebel LA.. (1991) Nicotinamide ethers: novel inhibitors of calcium-independent phosphodiesterase and [3H]rolipram binding., 34 (1): [PMID:1825116] [10.1021/jm00105a015] |